ClearTrial Awarded 2008 “Best Technological Development in Clinical Trials” by Good Clinical Practice JournalClearTrial clinical trial operations software recognized for helping life sciences organizations gain speed, accuracy, and flexibility in clinical development London, England – November 3, 2008 – ClearTrial (www.cleartrial.com), a leading provider of software for clinical trial operations planning, budgeting, and outsourcing, was presented with the prestigious GCPj (Good Clinical Practice Journal) Award for “Best Technological Development in Clinical Trials” at the annual GCPj awards ceremony. Judged by a distinguished panel of industry experts in clinical trials, the GCPj awards annually highlight the achievements of “the very best in the fields of clinical research.”“GCPj salutes the finalists and winners,” said Helena Jensen, Publisher of GCPj. “We are delighted to honor all of these dedicated professionals who are working so hard to bring innovative, safer and more effective medicines to market as quickly as possible.” ClearTrial clinical trial software helps biopharmaceutical companies and clinical research organizations (CROs) more effectively plan, budget, outsource, and optimize the operational design of clinical trials. ClearTrial software is now used by many of the largest biopharma organizations in the industry and by 5 of the top 10 biotech companies. ClearTrial’s customers in clinical operations, outsourcing, finance, and project management have been drawing on the web-based software’s innovative, easy-to-use design to apply a true activity-based planning approach to:
“On behalf of the entire ClearTrial team, I’d like to thank GCPj and the panel of distinguished clinical experts for their recognition of ClearTrial’s contributions to the industry,” noted Michael Soenen, Managing Partner of ClearTrial. “We share with GCPj the mission of improving clinical trial processes and standards, and our software provides life sciences organizations the planning speed, flexibility, and consistency they need in today’s demanding clinical development environment.” About ClearTrial® ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners. About GCPj For more information contact: Mike Lange |
